fMRIyellow

Caption 1. Difference in increases in CBF during the active premonitory phase relative to placebo (yellow) in the 2×2 ANOVA model (n=12).

Educational Partners and Supporters

This program is funded in part via an independent educational grant from AbbVie

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

fMRIyellow

Trials

Meeting Reports

Resources